Keynote B59
GI Innovation, Inc.
GI Innovation, Inc.
Merck Sharp & Dohme LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
Pfizer
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Kidney Cancer Research Bureau
Second Life Therapeutics
Ocellaris Pharma, Inc.
Tyra Biosciences, Inc
Hoffmann-La Roche
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
7 Hills Pharma, LLC
GI Innovation, Inc.
Incyte Corporation
Incyte Corporation
NuCana plc
CHU de Quebec-Universite Laval
Indiana University
PureTech
GI Innovation, Inc.
Salubris Biotherapeutics Inc
Hookipa Biotech GmbH
NextCure, Inc.
Processa Pharmaceuticals
Fred Hutchinson Cancer Center
Nektar Therapeutics
Nektar Therapeutics
Institut Bergonié
University of California, San Francisco
NKGen Biotech, Inc.
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Icahn School of Medicine at Mount Sinai
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
CureVac
Duke University
Dana-Farber Cancer Institute
Millennium Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
Bostwick Laboratories
Bristol-Myers Squibb
Johns Hopkins University
National Cancer Institute (NCI)
Providence Health & Services